Abeona Therapeutics Inc
ABEO
Market Cap$301.31M
Close$
$0.01
99.9% downside
Current Fair Value
99.9% downsideOvervalued by 99.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $301.31 Million |
|---|---|
| Enterprise Value | $314.37 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.55 |
| Beta | 1.55 |
| Outstanding Shares | 49,779,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.64 |
|---|---|
| PEG | 10.72 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.7 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Abeona Therapeutics Inc
CEO: Joao Siffert